Keywords: MR-Guided Radiotherapy, Radiotherapy
Motivation: Stereotactic MR-guided Adaptive Radiation Therapy (SMART) ‘dose painting’ for hypoxia can improve treatment outcomes, but implementation on MR-Linac (MRL) faces low-field SNR challenges. Optimization of T1-to-noise ratio at 0.35T will enable clinical implementation of oxygen-enhanced (OE)-MRI.
Goal(s): Develop and validate an optimized MP2RAGE sequence for low-field T1 mapping, establish feasibility and evaluate reproducibility in phantoms and healthy subjects.
Approach: We optimized and validated an MP2RAGE sequence with simulations and a ground-truth phantom. T1 mapping feasibility was established in healthy subjects, variability and reproducibility was assessed.
Results: A clinically feasible optimized low-field MP2RAGE protocol was developed, yielding accurate and reproducible T1 mapping.
Impact: This work builds a foundation towards clinically feasible hypoxia imaging for low-field MRL. This would facilitate a paradigm shift toward MR-guided biological adaptation and dose painting, leveraging the spatial distribution of hypoxia, and improving patient outcomes in conventionally challenging-to-treat cancers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords